WO2003064596A8 - Desaturase genes, enzymes encoded thereby, and uses thereof - Google Patents
Desaturase genes, enzymes encoded thereby, and uses thereofInfo
- Publication number
- WO2003064596A8 WO2003064596A8 PCT/US2003/001698 US0301698W WO03064596A8 WO 2003064596 A8 WO2003064596 A8 WO 2003064596A8 US 0301698 W US0301698 W US 0301698W WO 03064596 A8 WO03064596 A8 WO 03064596A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- desaturase
- isolated polynucleotides
- enzymes
- enzymes encoded
- epa
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
- C12N9/0083—Miscellaneous (1.14.99)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/04—Drugs for disorders of the urinary system for urolithiasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6409—Fatty acids
- C12P7/6427—Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6409—Fatty acids
- C12P7/6427—Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
- C12P7/6431—Linoleic acids [18:2[n-6]]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6409—Fatty acids
- C12P7/6427—Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
- C12P7/6432—Eicosapentaenoic acids [EPA]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6409—Fatty acids
- C12P7/6427—Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
- C12P7/6434—Docosahexenoic acids [DHA]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6436—Fatty acid esters
- C12P7/6445—Glycerides
- C12P7/6472—Glycerides containing polyunsaturated fatty acid [PUFA] residues, i.e. having two or more double bonds in their backbone
Abstract
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK03710700.0T DK1480993T4 (en) | 2002-01-30 | 2003-01-21 | Desaturase genes, enzymes encoded and applications thereof |
JP2003564192A JP4780916B2 (en) | 2002-01-30 | 2003-01-21 | Desaturase gene, enzyme encoded by said gene and use thereof |
CA2474894A CA2474894C (en) | 2002-01-30 | 2003-01-21 | Desaturase genes, enzymes encoded thereby, and uses thereof |
MXPA04007588A MXPA04007588A (en) | 2002-01-30 | 2003-01-21 | Desaturase genes, enzymes encoded thereby, and uses thereof. |
EP03710700A EP1480993B2 (en) | 2002-01-30 | 2003-01-21 | Desaturase genes, enzymes encoded thereby, and uses thereof |
DE60322515T DE60322515D1 (en) | 2002-01-30 | 2003-01-21 | DESATURASEGENE, OF THESE ENCYMES ENCODED AND USES THEREOF |
ES03710700T ES2310652T5 (en) | 2002-01-30 | 2003-01-21 | Desaturase genes, enzymes encoded by these genes and their use |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/060,793 | 2002-01-30 | ||
US10/060,793 US7211656B2 (en) | 2002-01-30 | 2002-01-30 | Desaturase genes, enzymes encoded thereby, and uses thereof |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2003064596A2 WO2003064596A2 (en) | 2003-08-07 |
WO2003064596A3 WO2003064596A3 (en) | 2003-12-04 |
WO2003064596A8 true WO2003064596A8 (en) | 2008-07-31 |
Family
ID=27658343
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2003/001698 WO2003064596A2 (en) | 2002-01-30 | 2003-01-21 | Desaturase genes, enzymes encoded thereby, and uses thereof |
Country Status (11)
Country | Link |
---|---|
US (3) | US7211656B2 (en) |
EP (1) | EP1480993B2 (en) |
JP (1) | JP4780916B2 (en) |
AT (1) | ATE402944T1 (en) |
CA (2) | CA2474894C (en) |
DE (1) | DE60322515D1 (en) |
DK (1) | DK1480993T4 (en) |
ES (1) | ES2310652T5 (en) |
MX (1) | MXPA04007588A (en) |
PT (1) | PT1480993E (en) |
WO (1) | WO2003064596A2 (en) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2439654A1 (en) * | 2001-03-12 | 2002-09-19 | The General Hospital Corporation | Compositions and methods for modifying the content of polyunsaturated fatty acids in mammalian cells |
US20040172682A1 (en) * | 2003-02-12 | 2004-09-02 | Kinney Anthony J. | Production of very long chain polyunsaturated fatty acids in oilseed plants |
US7214491B2 (en) * | 2003-05-07 | 2007-05-08 | E. I. Du Pont De Nemours And Company | Δ-12 desaturase gene suitable for altering levels of polyunsaturated fatty acids in oleaginous yeasts |
US8313911B2 (en) * | 2003-05-07 | 2012-11-20 | E I Du Pont De Nemours And Company | Production of polyunsaturated fatty acids in oleaginous yeasts |
US7125672B2 (en) * | 2003-05-07 | 2006-10-24 | E. I. Du Pont De Nemours And Company | Codon-optimized genes for the production of polyunsaturated fatty acids in oleaginous yeasts |
US7238482B2 (en) | 2003-05-07 | 2007-07-03 | E. I. Du Pont De Nemours And Company | Production of polyunsaturated fatty acids in oleaginous yeasts |
BRPI0413073A (en) | 2003-08-01 | 2006-10-03 | Basf Plant Science Gmbh | process for the production of compounds, oil, lipid or fatty acid, or a fraction thereof, oil, lipid or fatty acid composition, process for the production of oils, lipids or fatty acid compositions, use of oil, lipid or acids fatty acids or compositions of oil, lipid or fatty acid or oils, lipids or fatty acid compositions, isolated nucleic acid sequence, amino acid sequence, gene construct, vector, and transgenic non-human organism |
US7504259B2 (en) * | 2003-11-12 | 2009-03-17 | E. I. Du Pont De Nemours And Company | Δ12 desaturases suitable for altering levels of polyunsaturated fatty acids in oleaginous yeast |
JP4916886B2 (en) | 2003-11-12 | 2012-04-18 | イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー | Δ15 desaturase suitable for altering polyunsaturated fatty acid levels in oily plants and yeast |
BRPI0507466A (en) * | 2004-02-04 | 2007-07-10 | Gen Hospital Corp | compositions and methods for modifying polyunsaturated fatty acid content in biological cells |
EP2623584B1 (en) | 2004-02-27 | 2019-04-10 | BASF Plant Science GmbH | Method for producing polyunsatured fatty acids in transgenic plants |
AU2005217080B2 (en) * | 2004-02-27 | 2011-02-24 | Basf Plant Science Gmbh | Method for producing unsaturated omega-3 fatty acids in transgenic organisms |
US7834250B2 (en) | 2004-04-22 | 2010-11-16 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cells |
CN103451246B (en) | 2004-04-22 | 2018-02-16 | 联邦科学技术研究组织 | With recombinant cell synthesis of long-chain polyunsaturated fatty acids |
PT1766023E (en) * | 2004-06-04 | 2010-12-09 | Fluxome Sciences As | Metabolically engineered cells for the production of polyunsaturated fatty acids |
JP4587451B2 (en) * | 2004-08-20 | 2010-11-24 | サントリーホールディングス株式会社 | Polypeptide having ω3 fatty acid desaturation activity, polynucleotide encoding the polypeptide, and use thereof |
US7550286B2 (en) | 2004-11-04 | 2009-06-23 | E. I. Du Pont De Nemours And Company | Docosahexaenoic acid producing strains of Yarrowia lipolytica |
AR059376A1 (en) | 2006-02-21 | 2008-03-26 | Basf Plant Science Gmbh | PROCEDURE FOR THE PRODUCTION OF POLYINSATURATED FATTY ACIDS |
US7943823B2 (en) | 2006-04-28 | 2011-05-17 | E.I. Du Pont De Nemours And Company | Delta-8 desaturase and its use in making polyunsaturated fatty acids |
US20070254299A1 (en) * | 2006-05-01 | 2007-11-01 | Yadav Narendra S | Fungal delta 12 desaturase and delta 15 desaturase motifs |
US7695950B2 (en) * | 2006-05-17 | 2010-04-13 | E. I. Du Pont De Nemours And Company | Δ5 desaturase and its use in making polyunsaturated fatty acids |
US7678560B2 (en) * | 2006-05-17 | 2010-03-16 | E.I. Du Pont De Nemours And Company | Δ 5 desaturase and its use in making polyunsaturated fatty acids |
AU2013202498B2 (en) * | 2006-08-24 | 2015-04-30 | Basf Plant Science Gmbh | Isolation and characterization of a novel Pythium omega 3 desaturase with specificity to all omega 6 fatty acids longer than 18 carbon chains |
WO2008025068A1 (en) | 2006-08-29 | 2008-03-06 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of fatty acids |
CA2675207A1 (en) * | 2007-02-12 | 2008-07-21 | E. I. Du Pont De Nemours And Company | Production of arachidonic acid in oilseed plants |
US8957280B2 (en) | 2007-05-03 | 2015-02-17 | E. I. Du Pont De Nemours And Company | Delta-5 desaturases and their use in making polyunsaturated fatty acids |
DE102007058991A1 (en) | 2007-12-07 | 2009-06-25 | Bayer Materialscience Ag | The use of low-chloride, low-carbonate silica sand as retention material for solid acid catalysts, especially in solid-bed reactors for condensation reactions, preferably for production of Bisphenol A |
EP2149370A1 (en) * | 2008-07-31 | 2010-02-03 | Neuroscienze Pharmaness S.C. A R.L. | Diazabicyclic compounds and microemulsions thereof |
IT1390848B1 (en) * | 2008-07-31 | 2011-10-19 | Neuroscienze Pharmaness S C A R L | PHARMACEUTICAL COMPOUNDS |
BR122021003835B1 (en) | 2008-11-18 | 2022-02-08 | Grains Research And Development Corporation | ISOLATED AND/OR EXOGENOUS POLYNUCLEOTIDE THAT DOES NOT OCCUR IN A NATURAL WAY, VECTOR COMPRISING SUCH POLYNUCLEOTIDE AND PRODUCTION METHOD OF OIL CONTAINING UNSATURATED FATTY ACIDS |
EP2683824B1 (en) | 2011-03-07 | 2018-04-25 | DSM Nutritional Products AG | Engineering thraustochytrid microorganisms |
EP2836599B1 (en) | 2012-04-12 | 2019-11-06 | Rothamsted Research Limited | Production of omega-3 long chain polyunsaturated fatty acids |
MY187101A (en) | 2012-06-15 | 2021-08-31 | Commw Scient Ind Res Org | Production of long chain polyunsaturated fatty acids in plant cells |
GB201217524D0 (en) | 2012-10-01 | 2012-11-14 | Rothamsted Res Ltd | Recombinant organisms |
WO2014141098A1 (en) | 2013-03-13 | 2014-09-18 | Dsm Nutritional Products Ag | Engineering microorganisms |
EP3040415A4 (en) | 2013-08-27 | 2017-04-12 | Kyoto University | Omega-3 UNSATURATED FATTY ACID ENZYME AND METHOD FOR PRODUCING EICOSAPENTAENOIC ACID |
PE20170253A1 (en) | 2013-12-18 | 2017-04-14 | Nuseed Pty Ltd | LIPID INCLUDING LONG-CHAIN POLYINSATURATED FATTY ACIDS |
EP3160482A4 (en) | 2014-06-27 | 2018-02-14 | Commonwealth Scientific and Industrial Research Organisation | Lipid comprising docosapentaenoic acid |
US10538793B2 (en) | 2014-12-25 | 2020-01-21 | Kyoto University | ω3 fatty-acid desaturase and method for producing eicosapentaenoic acid |
Family Cites Families (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL63907A0 (en) | 1980-09-24 | 1981-12-31 | Cetus Corp | Diagnostic method and antibody probe for use therein |
DE3381518D1 (en) | 1982-01-22 | 1990-06-07 | Cetus Corp | METHOD FOR CHARACTERIZING HLA AND THE CDNS TEST AGENTS USED IN IT. |
US4582788A (en) | 1982-01-22 | 1986-04-15 | Cetus Corporation | HLA typing method and cDNA probes used therein |
US4683194A (en) * | 1984-05-29 | 1987-07-28 | Cetus Corporation | Method for detection of polymorphic restriction sites and nucleic acid sequences |
US4945050A (en) | 1984-11-13 | 1990-07-31 | Cornell Research Foundation, Inc. | Method for transporting substances into living cells and tissues and apparatus therefor |
US4943674A (en) * | 1987-05-26 | 1990-07-24 | Calgene, Inc. | Fruit specific transcriptional factors |
US5420034A (en) | 1986-07-31 | 1995-05-30 | Calgene, Inc. | Seed-specific transcriptional regulation |
GB8507058D0 (en) | 1985-03-19 | 1985-04-24 | Efamol Ltd | Pharmaceutical & dietary compositions |
US4683202A (en) * | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
GB8524275D0 (en) | 1985-10-02 | 1985-11-06 | Efamol Ltd | Pharmaceutical & dietary compositions |
GB8524276D0 (en) | 1985-10-02 | 1985-11-06 | Efamol Ltd | Pharmaceutical & dietary compositions |
CA1284931C (en) | 1986-03-13 | 1991-06-18 | Henry A. Erlich | Process for detecting specific nucleotide variations and genetic polymorphisms present in nucleic acids |
US5107065A (en) * | 1986-03-28 | 1992-04-21 | Calgene, Inc. | Anti-sense regulation of gene expression in plant cells |
US5188958A (en) | 1986-05-29 | 1993-02-23 | Calgene, Inc. | Transformation and foreign gene expression in brassica species |
CA1338457C (en) | 1986-08-22 | 1996-07-16 | Henry A. Erlich | Purified thermostable enzyme |
US5004863B2 (en) | 1986-12-03 | 2000-10-17 | Agracetus | Genetic engineering of cotton plants and lines |
US5416011A (en) | 1988-07-22 | 1995-05-16 | Monsanto Company | Method for soybean transformation and regeneration |
CA1338683C (en) | 1988-09-13 | 1996-10-29 | Efamol Holdings Plc | Fatty acid therapy and compositions |
US5231020A (en) * | 1989-03-30 | 1993-07-27 | Dna Plant Technology Corporation | Genetic engineering of novel plant phenotypes |
US5106739A (en) | 1989-04-18 | 1992-04-21 | Calgene, Inc. | CaMv 355 enhanced mannopine synthase promoter and method for using same |
US5175095A (en) | 1989-07-19 | 1992-12-29 | Calgene, Inc. | Ovary-tissue transcriptional factors |
EP0537178B2 (en) * | 1990-05-25 | 2007-06-13 | E.I. Du Pont De Nemours And Company | Nucleotide sequence of soybean stearoyl-acp desaturase gene |
EP0506959B1 (en) * | 1990-10-22 | 2000-09-06 | Aicello Chemical Company Limited | Method of engraving with image mask and photosensitive laminate film for said image mask |
US5658767A (en) * | 1991-01-24 | 1997-08-19 | Martek Corporation | Arachidonic acid and methods for the production and use thereof |
US5518908A (en) | 1991-09-23 | 1996-05-21 | Monsanto Company | Method of controlling insects |
PH31293A (en) * | 1991-10-10 | 1998-07-06 | Rhone Poulenc Agrochimie | Production of y-linolenic acid by a delta6-desaturage. |
US5614393A (en) * | 1991-10-10 | 1997-03-25 | Rhone-Poulenc Agrochimie | Production of γ-linolenic acid by a Δ6-desaturase |
EP0616644B1 (en) | 1991-12-04 | 2003-07-02 | E.I. Du Pont De Nemours And Company | Fatty acid desaturase genes from plants |
US5912120A (en) | 1992-04-09 | 1999-06-15 | The United States Of America As Represented By The Department Of Health And Human Services, | Cloning, expression and diagnosis of human cytochrome P450 2C19: the principal determinant of s-mephenytoin metabolism |
WO1994011516A1 (en) | 1992-11-17 | 1994-05-26 | E.I. Du Pont De Nemours And Company | Genes for microsomal delta-12 fatty acid desaturases and related enzymes from plants |
EP0686197B1 (en) | 1993-02-26 | 2000-06-07 | Calgene LLC | Geminivirus-based gene expression system |
DE4339010C2 (en) * | 1993-06-25 | 2000-05-18 | Pt Sub Inc | Photohardenable product for printing plates |
WO1995024494A1 (en) | 1994-03-09 | 1995-09-14 | Abbott Laboratories | Humanized milk |
US5750176A (en) * | 1994-03-09 | 1998-05-12 | Abbott Laboratories | Transgenic non-human mammal milk comprising 2'-fucosyl-lactose |
NZ281041A (en) * | 1994-03-09 | 1998-04-27 | Abbott Lab | Non-human mammals transformed with a catalytic entity of enzymes or antibodies to produce a heterologous product in the animals milk |
US5922506A (en) * | 1994-10-20 | 1999-07-13 | Agfa-Gevaert, N.V. | Imaging element comprising a hydrophobic photopolymerizable composition and method for producing lithographic plates therewith |
US5631152A (en) | 1994-10-26 | 1997-05-20 | Monsanto Company | Rapid and efficient regeneration of transgenic plants |
US5654402A (en) | 1994-10-26 | 1997-08-05 | Michigan State University | Methods and compositions relating to plant Δ6 palmitoyl-acyl carrier protein desaturase |
US5677108A (en) * | 1995-04-28 | 1997-10-14 | Polaroid Corporation | On-press removable quenching overcoat for lithographic plates |
US6143470A (en) * | 1995-06-23 | 2000-11-07 | Nguyen; My T. | Digital laser imagable lithographic printing plates |
US5820932A (en) * | 1995-11-30 | 1998-10-13 | Sun Chemical Corporation | Process for the production of lithographic printing plates |
US6140005A (en) * | 1996-04-23 | 2000-10-31 | Agfa-Gevaert, N.V. | Imaging element and a method for producing a lithographic plate therewith |
JP3995290B2 (en) * | 1996-08-23 | 2007-10-24 | サントリー株式会社 | Method for producing omega-9 polyunsaturated fatty acid and lipid containing the same |
US6106992A (en) * | 1996-11-14 | 2000-08-22 | Dai Nippon Printing Co., Ltd. | Photoresist film and process for producing back plate of plasma display panel |
US6194167B1 (en) | 1997-02-18 | 2001-02-27 | Washington State University Research Foundation | ω-3 fatty acid desaturase |
US5968809A (en) * | 1997-04-11 | 1999-10-19 | Abbot Laboratories | Methods and compositions for synthesis of long chain poly-unsaturated fatty acids |
PL336077A1 (en) † | 1997-04-11 | 2000-06-05 | Calgene Llc | Methods of and compositions for synthesising long-chain polyunsaturated fatty acids in plants |
US7008664B1 (en) * | 1998-06-11 | 2006-03-07 | E. I. Du Pont De Nemours And Company | Method for improving the carcass quality of an animal |
US6403349B1 (en) * | 1998-09-02 | 2002-06-11 | Abbott Laboratories | Elongase gene and uses thereof |
DE19941609A1 (en) * | 1999-09-01 | 2001-03-08 | Inst Pflanzenbiochemie Ipb | Fatty acid desaturase gene from plants |
JP2001169731A (en) * | 1999-12-17 | 2001-06-26 | Showa Denko Kk | Lipid metabolism improving agent for animal |
GB0016452D0 (en) * | 2000-07-04 | 2000-08-23 | Kilgowan Limited | Vitamin K and essential fatty acids |
US6849383B2 (en) * | 2000-07-26 | 2005-02-01 | Toyo Boseki Kabushiki Kaisha | Photosensitive resin laminate, and signboard plate and signboard made of the laminate |
TWI324181B (en) * | 2001-04-16 | 2010-05-01 | Martek Biosciences Corp | Product and process for transformation of thraustochytriales microorganisms |
-
2002
- 2002-01-30 US US10/060,793 patent/US7211656B2/en not_active Expired - Fee Related
-
2003
- 2003-01-21 CA CA2474894A patent/CA2474894C/en not_active Expired - Fee Related
- 2003-01-21 PT PT03710700T patent/PT1480993E/en unknown
- 2003-01-21 JP JP2003564192A patent/JP4780916B2/en not_active Expired - Fee Related
- 2003-01-21 DK DK03710700.0T patent/DK1480993T4/en active
- 2003-01-21 DE DE60322515T patent/DE60322515D1/en not_active Expired - Lifetime
- 2003-01-21 ES ES03710700T patent/ES2310652T5/en not_active Expired - Lifetime
- 2003-01-21 EP EP03710700A patent/EP1480993B2/en not_active Expired - Lifetime
- 2003-01-21 CA CA2714295A patent/CA2714295C/en not_active Expired - Fee Related
- 2003-01-21 WO PCT/US2003/001698 patent/WO2003064596A2/en active Search and Examination
- 2003-01-21 MX MXPA04007588A patent/MXPA04007588A/en active IP Right Grant
- 2003-01-21 AT AT03710700T patent/ATE402944T1/en active
-
2007
- 2007-01-09 US US11/621,446 patent/US7723503B2/en not_active Expired - Fee Related
-
2009
- 2009-03-23 US US12/409,211 patent/US8067674B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2714295A1 (en) | 2003-08-07 |
US7211656B2 (en) | 2007-05-01 |
US20030196217A1 (en) | 2003-10-16 |
DE60322515D1 (en) | 2008-09-11 |
EP1480993B1 (en) | 2008-07-30 |
EP1480993B2 (en) | 2012-05-16 |
US7723503B2 (en) | 2010-05-25 |
DK1480993T4 (en) | 2012-08-13 |
ES2310652T3 (en) | 2009-01-16 |
JP2005515776A (en) | 2005-06-02 |
CA2474894A1 (en) | 2003-08-07 |
US20090226987A1 (en) | 2009-09-10 |
US20070124837A1 (en) | 2007-05-31 |
EP1480993A2 (en) | 2004-12-01 |
DK1480993T3 (en) | 2008-11-24 |
JP4780916B2 (en) | 2011-09-28 |
PT1480993E (en) | 2008-11-06 |
WO2003064596A3 (en) | 2003-12-04 |
MXPA04007588A (en) | 2004-12-06 |
ES2310652T5 (en) | 2012-07-02 |
ATE402944T1 (en) | 2008-08-15 |
US8067674B2 (en) | 2011-11-29 |
WO2003064596A2 (en) | 2003-08-07 |
CA2714295C (en) | 2013-05-28 |
CA2474894C (en) | 2012-07-03 |
EP1480993A4 (en) | 2006-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003064596A3 (en) | Desaturase genes, enzymes encoded thereby, and uses thereof | |
WO2005047479A3 (en) | Delta-15 desaturases suitable for altering levels of polyunsaturated fatty acids in oilseed plants and oleaginous yeast | |
WO2005047485A3 (en) | Delta12 desaturases suitable for altering levels of polyunsaturated fatty acids in oleaginous yeast | |
MXPA03006663A (en) | Desaturase genes and uses thereof. | |
WO2000012720A8 (en) | Elongase genes and uses thereof | |
Xue et al. | Production of omega-3 eicosapentaenoic acid by metabolic engineering of Yarrowia lipolytica | |
EP2392664A3 (en) | Production of polyunsaturated fatty acids in oleaginous yeasts | |
WO2000040705A3 (en) | Human desaturase gene and uses thereof | |
MXPA03000750A (en) | Elongase genes and uses thereof. | |
WO2002090493A3 (en) | Δ4-desaturase genes and uses thereof | |
WO2004104167A3 (en) | A δ-12 desaturase gene suitable for altering levels of polyunsaturated fatty acids in oleaginous yeasts | |
WO2003099216A3 (en) | Fatty acid desaturases from fungi | |
WO2006052870A3 (en) | High eicosapentaenoic acid producing strains of yarrowia lipolytica | |
WO2002057465A3 (en) | Method for producing polyunsaturated fatty acids, novel biosynthesis genes and novel plant expression constructs | |
EP1726652A3 (en) | Delta 6-desaturases from primulaceae, expressing plants and PUFA-containing oils | |
NZ337457A (en) | Synthesis of long chain polyunsaturated fatty acids, omega-3 and omega-6 fatty acids, specifically eicosapentaenoic acid and arachidonic acid | |
WO2007136671A3 (en) | Delta5 desaturase and its use in making polyunsaturated fatty acids | |
WO2004090123A3 (en) | Δ-4 desaturases from euglena gracilis, expressing plants, and oils containing pufa | |
WO2004057001A3 (en) | Method for the production of polyunsaturated fatty acids | |
WO2007136646A3 (en) | Delta5 desaturase and its use in making polyunsaturated fatty acids | |
WO2004101753A3 (en) | Codon-optimized genes for the production of polyunsaturated fatty acids in oleaginous yeasts | |
DE50013231D1 (en) | DELTA6 ACETYLENASE AND DELTA6 DESATURASE FROM CERATODON PURPUREUS | |
WO2003102138A3 (en) | Elongase genes and uses thereof | |
NO20071180L (en) | Delta 6 desaturase genes and uses thereof | |
WO2008073275A3 (en) | Mutant delta-8 desaturase genes engineered by targeted mutagensis and their use in making polyunsaturated fatty acids |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): CA JP MX NO |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2003564192 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2474894 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2004/007588 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003710700 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2003710700 Country of ref document: EP |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) |